GENB – Generate Biomedicines Inc
Investors holding2
Combined shares1,994,264
Combined reported value$30.0M
GENB chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Cathie Wood | 0.17 | Added 52.9% | 1,964,661 | $29.5M | Q3 2026 |
| Paul Tudor Jones narrow view | 0.00 | New | 29,603 | $445K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 52.9% | 1,964,661 | 0.06 |
| Q3 2026 | Paul Tudor Jones narrow view | New | 29,603 | 0.00 |
| Q2 2026 | Cathie Wood | Added 157.7% | 1,284,617 | 0.09 |
| Q2 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
| Q1 2026 | Cathie Wood | New | 498,408 | 0.05 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 23,833 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 52.9% | 1,964,661 | 0.06 |
| Q3 2026 | Paul Tudor Jones narrow view | New | 29,603 | 0.00 |
| Q2 2026 | Cathie Wood | Added 157.7% | 1,284,617 | 0.09 |
| Q1 2026 | Cathie Wood | New | 498,408 | 0.05 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 23,833 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
History
2 peakQ3 2026: 2 tracked investors
20262026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 1.96M | 1.28M | 498.4K | – | – | – | – | – |
| Paul Tudor Jones | 29.6K | – | 23.8K | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).